|Articles|October 27, 2022

Boehringer Ingelheim Extends Use of Medidata Rave

Collaboration in EDC renewed for another five years.

Medidata and Boehringer Ingelheim announced a five-year renewal of their collaboration in the area of electronic data capture. The new agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata.

Read more about the collaboration here.


Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content